Metabolic syndrome, fatty liver, and CKD
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. those who received physical examinations and health checkup services at MedCity21, a clinic affiliated with the Department of Premier Preventive Medicine, Osaka Metropolitan University Hospital, or a collaborating research institute between April 2014 and March 2032 2. be at least 18 years of age at the time of initial consent
Exclusion criteria
Exclusion criteria: nothing in particular
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not set | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Frequency of metabolic syndrome (2) Frequency of NAFLD and MAFLD, percentage by gender and BMI (3) Proportion of patients with advanced fibrosis according to cutoff value of FIB-4 by age (4) CKD stage and percentage (5) Variations in various test items among those who visited the hospital during the first year and visited again after a certain period of time (6) Association of the above items with biochemical data related to lifestyle-related diseases, abdominal echocardiographic findings, medical interview and disease data | — |
Countries
Japan
Contacts
Graduate School of Medicine, Osaka Metropolitan University Department of Hepatology